| Name: | Canagliflozin Tetraacetate |
| Catalogue No. | VE007519 |
| CAS No. | 866607-35-4 |
| Molecular Formula | C32H33FO9S |
| Molecular Weight | 612.66 g/mol |
| Status | In-Stock |
| IUPAC Name | (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-Tetraacetate |
| Description | Canagliflozin Tetraacetate (CAS No: 866607-35-4) Or (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-Tetraacetate,Canagliflozin Tetraacetate is an intermediate in the synthesis of Canagliflozin, which is a sodium/glucose cotransporter 2 inhibitor,which is used in treatment of type 2 diabetes and obesity. |
| References | Sci-Hub | Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease | 10.1007/s00125-019-4859-4. (2019). Retrieved December 31, 2021, from Sci-hub.ee website: https://sci-hub.ee/10.1007/s00125-019-4859-4 |
